These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 46019)

  • 1. Cyclophosphamide treatment in steroid-sensitive nephrotic syndrome of childhood.
    Barratt TM; Bercowsky A; Osofsky SG; Soothill JF
    Lancet; 1975 Jan; 1(7898):55-8. PubMed ID: 46019
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Idiopathic nephrotic syndrome of childhood: cyclophosphamide induced conversion from steroid refractory to highly steroid sensitive disease.
    Bergstrand A; Bollgren I; Samuelsson A; Törnroth T; Wasserman J; Winberg J
    Clin Nephrol; 1973; 1(5):302-6. PubMed ID: 4129067
    [No Abstract]   [Full Text] [Related]  

  • 3. Therapeutic and toxic effects observed with different dosage programs of cyclophosphamide in treatment of steroid-responsive but frequently relapsing nephrotic syndrome.
    McCrory WW; Shibuya M; Lu WH; Lewy JE
    J Pediatr; 1973 Apr; 82(4):614-8. PubMed ID: 4698338
    [No Abstract]   [Full Text] [Related]  

  • 4. Treatment with tacrolimus and prednisolone is preferable to intravenous cyclophosphamide as the initial therapy for children with steroid-resistant nephrotic syndrome.
    Gulati A; Sinha A; Gupta A; Kanitkar M; Sreenivas V; Sharma J; Mantan M; Agarwal I; Dinda AK; Hari P; Bagga A
    Kidney Int; 2012 Nov; 82(10):1130-5. PubMed ID: 22763815
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential protein clearances and response to treatment in Nigerian nephrotic children.
    Adeniyi A; Hendrickse RG; Soothill JF
    Arch Dis Child; 1976 Sep; 51(9):691-6. PubMed ID: 793539
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Short-term cyclophosphamide in corticosteroid treated childhood nephrosis.
    Sheth KJ; Liu CC; Good TA
    Wis Med J; 1974 May; 73(5):S55-60. PubMed ID: 4830366
    [No Abstract]   [Full Text] [Related]  

  • 7. Comparative trial of 2 weeks and 8 weeks cyclophosphamide in steroid-sensitive relapsing nephrotic syndrome of childhood.
    Barratt TM; Cameron JS; Chantler C; Ogg CS; Soothill JF
    Arch Dis Child; 1973 Apr; 48(4):286-90. PubMed ID: 4574639
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment course of steroid-dependent nephrotic syndrome: emphasized on treatment effect.
    Chen SY; Wu CY; Tsai IJ; Tsau YK
    Nephrology (Carlton); 2010 Apr; 15(3):336-9. PubMed ID: 20470303
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intravenous cyclophosphamide in steroid-resistant nephrotic syndrome.
    Bajpai A; Bagga A; Hari P; Dinda A; Srivastava RN
    Pediatr Nephrol; 2003 Apr; 18(4):351-6. PubMed ID: 12700961
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cyclosporine in the treatment of childhood idiopathic steroid resistant nephrotic syndrome: a single centre experience in Nigeria.
    Ladapo TA; Esezobor CI; Lesi FE
    Pan Afr Med J; 2016; 25():258. PubMed ID: 28293374
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pulse cyclophosphamide therapy in steroid-dependent nephrotic syndrome.
    Prasad N; Gulati S; Sharma RK; Singh U; Ahmed M
    Pediatr Nephrol; 2004 May; 19(5):494-8. PubMed ID: 15015070
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term follow-up of cyclophosphamide therapy in frequent relapsing minimal lesion nephrotic syndrome.
    Chiu J; Drummond KN
    J Pediatr; 1974 Jun; 84(6):825-30. PubMed ID: 4855503
    [No Abstract]   [Full Text] [Related]  

  • 13. How to manage a child with steroid-responsive nephrotic syndrome when dose of prednisolone is reduced or when placed on high-dose alternate day steroids.
    Niaudet P
    Pediatr Nephrol; 1992 Nov; 6(6):522. PubMed ID: 1482637
    [No Abstract]   [Full Text] [Related]  

  • 14. Long-term stability of remission in nephrotic syndrome after treatment with cyclophosphamide.
    Cameron JS; Chantler C; Ogg CS; White RH
    Br Med J; 1974 Oct; 4(5935):7-11. PubMed ID: 4425844
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Use of cyclophosphamide and corticoids in the treatment of nephrotic syndrome: controlled study].
    Rocha H; Vaccaro Torres CE; Lessa I; Azevêdo Vinhaes L
    Rev Bras Pesqui Med Biol; 1972; 5(1-2):21-8. PubMed ID: 4680451
    [No Abstract]   [Full Text] [Related]  

  • 16. The idiopathic nephrotic syndrome of childhood. A clinical reevaluation of 148 cases.
    Makker SP; Heymann W
    Am J Dis Child; 1974 Jun; 127(6):830-7. PubMed ID: 4834775
    [No Abstract]   [Full Text] [Related]  

  • 17. Prospective, controlled trial of cyclophosphamide therapy in children with nephrotic syndrome. Report of the International study of Kidney Disease in Children.
    Lancet; 1974 Aug; 2(7878):423-7. PubMed ID: 4137139
    [No Abstract]   [Full Text] [Related]  

  • 18. Influence of prolonged corticosteroid therapy on the outcome of steroid-responsive nephrotic syndrome.
    Matsukura H; Inaba S; Shinozaki K; Yanagihara T; Hara M; Higuchi A; Takada T; Tanizawa T; Miyawaki T
    Am J Nephrol; 2001; 21(5):362-7. PubMed ID: 11684795
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyclophosphamide therapy in the nephrotic syndrome in childhood.
    Moncrieff MW; White RH; Oggs CS; Cameron JS
    Br Med J; 1969 Mar; 1(5645):666-71. PubMed ID: 5774315
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclophosphamide in the treatment of idiopathic nephrotic syndrome.
    Pennisi AJ; Grushkin CM; Lieberman E
    Pediatrics; 1976 Jun; 57(6):948-51. PubMed ID: 934751
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.